Abstract
Objective: To conduct an integrative review of serum levels of antioxidants and the effects of their supplementation on people living with HIV (PLHIV). Methods: A research was performed in the electronic databases LILACS and MEDLINE, using the descriptors "HIV" AND "antioxidants"; 110 publications were identified, 92 of which were available in the MEDLINE database and 3 in the LILACS database. After applying the exclusion criteria, 8 articles were selected for final evaluation.Results: The studies selected for the review were divided into 4 prospective observational studies and 4 clinical trials with supplementation of antioxidants or food sources of antioxidants. We observed that the initiation of antiretroviral therapy and its prolonged use negatively influenced the parameters of oxidative stress, and that deficiency of antioxidants was associated with more significant damage to mitochondrial DNA. Supplementation of foods that are sources of antioxidants, such as dark chocolate and spirulina, has had beneficial effects on serum lipids and antioxidant capacity. Conclusion: Clinical trials with a more robust methodology, supplementation of isolated nutrients, for more extended periods of intervention, and with the assessment of food consumption are necessary to elucidate their effects on oxidative stress in PLHIV faced with factors such as the use of antiretroviral therapy and changes in metabolic rates of this population.
Publisher
Revista Ciencias em Saude
Reference25 articles.
1. Silva MM. Polimorfismo da região do Fator de Necrose Tumoral (TNF) na síndrome da lipodistrofia associada à terapia anti-retroviral em portadores do HIV-1 [Dissertação de Mestrado]. Ribeirão Preto, SP: Curso de Enfermagem, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo; 2008. 154 p.
2. Deresz LF, Lazzarotto AR, Manfroi WC, Gaya A, Sprinz E, Oliveira AR, et al. O estresse oxidativo e o exercício físico em indivíduos HIV positivo. Rev Bras Med Esporte. 2007;13(4):275-9. https://doi.org/10.1590/S1517-86922007000400013
3. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186(7):1023-7. https://doi.org/10.1086/343862 PMid:12232845
4. Meng Q, Lima JAC, Lai H, Vlahov D, Celentano DD, Strathdee SA, et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J. 2002;144(4):642-8. https://doi.org/10.1067/mhj.2002.125009 PMID:12360160
5. UNAIDS. Communities at the Centre Global AIDS Update 2019 [Internet]. [cited 2021 May 2]. Avaiable from: https://bit.ly/3aTcsNg